Antiviral Res

1. DO TND, Abdelnabi R, Boda B, Constant S, et al
   The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model.
   Antiviral Res. 2024 Sep 3:105994. doi: 10.1016/j.antiviral.2024.105994.
   

   >> Share

   
   

   
   BMJ

2. ROBINSON A
   Identifying long covid in children ... and other research.
   BMJ. 2024;386:q1912.
   

   >> Share

   
   
3. MCKEE R, Hiam L, Klaber B
   Citizens' assemblies, health, and health policy.
   BMJ. 2024;386:q1886.
   

   >> Share

   
   
4. MACDONALD BK
   Public engagement in defining triage before future pandemics.
   BMJ. 2024;386:q1929.
   

   >> Share

   
   
5. 
   Seven days in medicine: 28 Aug to 3 Sep 2024.
   BMJ. 2024;386:q1913.
   

   >> Share

   
   
6. MCNALLY S
   Scarlett McNally: Volunteering and charity work offer massive health and community benefits.
   BMJ. 2024;386:q1887.
   

   >> Share

   
   

   
   Infect Control Hosp Epidemiol

7. CHIOTOS K, Lee G, Sydney G, Woods-Hill C, et al
   Impact of a tracheal aspirate culture diagnostic test stewardship intervention in a tertiary care PICU.
   Infect Control Hosp Epidemiol. 2024 Sep 4:1-9. doi: 10.1017/ice.2024.
   

   >> Share

   
   
8. GRANT R, Rubin M, Abbas M, Pittet D, et al
   Expanding the use of mathematical modeling in healthcare epidemiology and infection prevention and control.
   Infect Control Hosp Epidemiol. 2024 Sep 4:1-6. doi: 10.1017/ice.2024.
   

   >> Share

   
   

   
   Int J Infect Dis

9. BEEGLE K, Demombynes G, de Walque D, Gubbins P, et al
   COVID-19 Increased Existing Gender Mortality Gaps in High Income More than Middle Income Countries.
   Int J Infect Dis. 2024 Sep 2:107167. doi: 10.1016/j.ijid.2024.107167.
   

   >> Share

   
   
10. LASTRUCCI V, Pacifici M, Puglia M, Alderotti G, et al
    Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study.
    Int J Infect Dis. 2024 Aug 31:107231. doi: 10.1016/j.ijid.2024.107231.
    

    >> Share

    
    

    
    Intensive Care Med

11. SUNDARAM T, Sathishkumar K
    Towards improved management of pulmonary herpes simplex virus and cytomegalovirus in COVID-19 ARDS: a future perspective.
    Intensive Care Med. 2024 Sep 2. doi: 10.1007/s00134-024-07636.
    

    >> Share

    
    
12. ZENG G, Wang L
    Awake prone positioning for COVID-19 patients with acute respiratory failure: unknown appropriate duration.
    Intensive Care Med. 2024 Sep 2. doi: 10.1007/s00134-024-07637.
    

    >> Share

    
    
13. CRESCIOLI E, Nielsen FM, Bunzel AM, Eriksen ASB, et al
    Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemia.
    Intensive Care Med. 2024 Sep 5. doi: 10.1007/s00134-024-07613.
    

    >> Share

    
    
14. SATHISHKUMAR K
    Comparative efficacy of prolonged versus shorter awake prone positioning in managing acute respiratory failure in COVID-19 Patients. A Clinical Assessment.
    Intensive Care Med. 2024 Sep 2. doi: 10.1007/s00134-024-07621.
    

    >> Share

    
    

    
    J Infect

15. AZIZ AB, Sugimoto JD, Hong SL, You YA, et al
    Indirect effectiveness of a novel SAR-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines: a cluster randomised analysis.
    J Infect. 2024 Aug 30:106260. doi: 10.1016/j.jinf.2024.106260.
    

    >> Share

    
    
16. GRAM MA, Thiesson EM, Pihlstrom N, Perala J, et al
    Comparative effectiveness of bivalent BA.4-5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: A nationwide cohort study.
    J Infect. 2024;89:106261.
    

    >> Share

    
    
17. HASAN T, Zhu NJ, Pearson C, Aylin P, et al
    Increased 30-day all-cause mortality associated with Gram-negative bloodstream infections in England during the COVID-19 pandemic.
    J Infect. 2024 Aug 29:106256. doi: 10.1016/j.jinf.2024.106256.
    

    >> Share

    
    
18. HOBBS FR, Gbinigie OA, Shanyinde M, Yu LM, et al
    Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
    J Infect. 2024 Aug 29:106248. doi: 10.1016/j.jinf.2024.106248.
    

    >> Share

    
    

    
    J Med Virol

19. LO VT, Lim HA, Jang SS, Kim MC, et al
    N121T and N121S substitutions on the SARS-CoV-2 spike protein impact on serum neutralization.
    J Med Virol. 2024;96:e29871.
    

    >> Share

    
    
20. ZHOU Y, Feng W, Yang C, Wei X, et al
    E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting proteasome-dependent degradation of NSP5.
    J Med Virol. 2024;96:e29891.
    

    >> Share

    
    

    
    J Virol

21. SOUDANI N, Bricker TL, Darling T, Seehra K, et al
    Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters.
    J Virol. 2024 Sep 4:e0052824. doi: 10.1128/jvi.00528.
    

    >> Share

    
    

    
    JAMA

22. 
    Audio Highlights.
    JAMA. 2024;332:e2318388.
    

    >> Share

    
    
23. SURIE D, Self WH, Zhu Y, Yuengling KA, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older.
    JAMA. 2024 Sep 4:e2415775. doi: 10.1001/jama.2024.15775.
    

    >> Share

    
    
24. RUBIN R
    The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.16432.
    

    >> Share

    
    
25. ANDERER S
    CDC: Overall Deaths, Especially From COVID-19, Lower in 2023.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.17606.
    

    >> Share

    
    

    
    Lancet

26. MACNAUGHTON J, Zeiler K
    Reimagining illness through post-COVID-19 condition: the need for radically interdisciplinary health research.
    Lancet. 2024;404:840-841.
    

    >> Share

    
    

    
    Lancet Infect Dis

27. ISA F, Gonzalez Ortiz AM, Meyer J, Hamilton JD, et al
    Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial.
    Lancet Infect Dis. 2024 Sep 2:S1473-3099(24)00421.
    

    >> Share

    
    
28. BLOTT J
    Facing COVID-19 in South Africa.
    Lancet Infect Dis. 2024 Sep 2:S1473-3099(24)00583.
    

    >> Share

    
    
29. BAUER DLV
    Weighing up monoclonals and vaccination against COVID-19.
    Lancet Infect Dis. 2024 Sep 2:S1473-3099(24)00559.
    

    >> Share

    
    

    
    N Engl J Med

30. ROTTER LK
    "Do You Feel Safe at Home?".
    N Engl J Med. 2024;391:785-787.
    

    >> Share

    
    
31. ASHINA M, Phul R, Khodaie M, Lof E, et al
    A Monoclonal Antibody to PACAP for Migraine Prevention.
    N Engl J Med. 2024;391:800-809.
    

    >> Share

    
    

    
    Nature

32. LAKSHMIKANTH T, Consiglio C, Sardh F, Forlin R, et al
    Immune system adaptation during gender-affirming testosterone treatment.
    Nature. 2024;633:155-164.
    

    >> Share

    
    
33. ZHAO J, Wan W, Yu K, Lemey P, et al
    Farmed fur animals harbour viruses with zoonotic spillover potential.
    Nature. 2024 Sep 4. doi: 10.1038/s41586-024-07901.
    

    >> Share

    
    
34. NARASIMHAN H, Cheon IS, Qian W, Hu SS, et al
    An aberrant immune-epithelial progenitor niche drives viral lung sequelae.
    Nature. 2024 Sep 4. doi: 10.1038/s41586-024-07926.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share